- Home
- DCTH vs ZH Comparison
DCTH vs ZH Comparison
Compare DCTH & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- ZH
- Stock Information
- Founded
- DCTH 1988
- ZH 2011
- Country
- DCTH United States
- ZH China
- Employees
- DCTH N/A
- ZH N/A
- Industry
- DCTH Medical/Dental Instruments
- ZH Business Services
- Sector
- DCTH Health Care
- ZH Consumer Discretionary
- Exchange
- DCTH Nasdaq
- ZH Nasdaq
- Market Cap
- DCTH 388.3M
- ZH 432.6M
- IPO Year
- DCTH N/A
- ZH 2021
- Fundamental
- Price
- DCTH $11.10
- ZH $4.97
- Analyst Decision
- DCTH Strong Buy
- ZH Strong Buy
- Analyst Count
- DCTH 4
- ZH 1
- Target Price
- DCTH $24.50
- ZH $4.70
- AVG Volume (30 Days)
- DCTH 681.8K
- ZH 320.5K
- Earning Date
- DCTH 11-07-2025
- ZH 11-25-2025
- Dividend Yield
- DCTH N/A
- ZH N/A
- EPS Growth
- DCTH N/A
- ZH N/A
- EPS
- DCTH 0.06
- ZH 0.22
- Revenue
- DCTH $70,240,000.00
- ZH $439,821,184.00
- Revenue This Year
- DCTH $159.22
- ZH N/A
- Revenue Next Year
- DCTH $42.78
- ZH $6.47
- P/E Ratio
- DCTH $197.68
- ZH $21.98
- Revenue Growth
- DCTH 491.35
- ZH N/A
- 52 Week Low
- DCTH $8.08
- ZH $3.13
- 52 Week High
- DCTH $18.23
- ZH $6.32
- Technical
- Relative Strength Index (RSI)
- DCTH 45.00
- ZH 46.79
- Support Level
- DCTH $10.43
- ZH $4.85
- Resistance Level
- DCTH $11.28
- ZH $5.09
- Average True Range (ATR)
- DCTH 0.41
- ZH 0.21
- MACD
- DCTH -0.02
- ZH -0.05
- Stochastic Oscillator
- DCTH 23.22
- ZH 10.17
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.